000 | 01121 a2200313 4500 | ||
---|---|---|---|
005 | 20250513183716.0 | ||
264 | 0 | _c19990623 | |
008 | 199906s 0 0 eng d | ||
022 | _a0512-3054 | ||
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_aWHO Expert Committee on Specifications for Pharmaceutical Preparations. _h[electronic resource] |
260 |
_bWorld Health Organization technical report series _c1999 |
||
300 |
_ai-vi, 1-156 p. _bdigital |
||
500 | _aPublication Type: Technical Report; Journal Article | ||
650 | 0 | 4 |
_aDrug Compounding _xstandards |
650 | 0 | 4 |
_aDrug Industry _xstandards |
650 | 0 | 4 | _aDrug and Narcotic Control |
650 | 0 | 4 | _aFacility Regulation and Control |
650 | 0 | 4 | _aGlobal Health |
650 | 0 | 4 | _aGuidelines as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLegislation, Drug |
650 | 0 | 4 |
_aPharmaceutical Preparations _xstandards |
650 | 0 | 4 |
_aPharmacies _xstandards |
650 | 0 | 4 | _aPharmacopoeias as Topic |
650 | 0 | 4 | _aQuality Assurance, Health Care |
650 | 0 | 4 | _aReference Standards |
773 | 0 |
_tWorld Health Organization technical report series _gvol. 885 _gp. i-vi, 1-156 |
|
999 |
_c10311211 _d10311211 |